Angina: Symptoms, Causes, Treatment & Nursing Care

Angina pectoris is symptomatic myocardial ischaemia: transient mismatch between coronary blood flow and myocardial oxygen demand that patients experience as pressure, tightness, or squeezing across the precordium, sometimes with dyspnoea or faintness rather than classic “pain” wording. In outpatient and ward settings most encounters concern chronic coronary disease (historically “stable” ischaemic heart disease) where exertion, cold, emotion, or heavy meals reproducibly trigger discomfort that eases within minutes once demand falls or short-acting nitrates act.

The substrate is usually flow-limiting epicardial atherosclerosis, although vasospastic and microvascular mechanisms produce anginal equivalents even when angiograms look unobstructed. Framing symptoms within CCS (Canadian Cardiovascular Society) functional class clarifies how much ordinary activity is curtailed and gives nurses a lingua franca when handing patients between primary care, rapid-access chest-pain clinics, catheter suites, and cardiac rehabilitation.

Use CCS class to track symptomatic burden over time (whether on optimal medical therapy), justify urgency of specialist review, and document trends after revascularisation. Class I–IV describe limitation by angina rather than anatomic stenosis severity alone.

↔On a small screen, swipe or scroll sideways to see the full table.

Typical angina bundles substernal pressure radiating to jaw, shoulder, or ulnar forearm, often accompanied by dyspnoea, diaphoresis, or nausea. Dyspnoea or fatigue without frank pain remains ischaemic until clinicians state otherwise, particularly in older adults, people with type 2 diabetes, and many female patients.

Patterns to chart clearly

• Provocation (exertion, cold, after large meal), duration, radiation, relieving factors (rest, GTN), and number of tablets used.
• Orthopnoea or paroxysmal nocturnal dyspnoea pointing toward heart failure comorbidity rather than pure exertional stable angina.
• Palpitations with dizziness—correlate with rate/rhythm on telemetry or ECG capture.

Atypical but high-risk descriptors

• Isolated epigastric burning mimicking reflux yet occurring with exertion—overlap with reflux disease should not delay objective testing when risk strata warrant.
• Exertional dyspnoea out of proportion to lung disease or anaemia.

Non-modifiable contributors include age, male-pattern risk in mid-life (female risk accelerates post-menopause), and family history. Modifiable drivers cluster around atherogenic lipids, tobacco, obesity-related metabolic stress, untreated hypertension, chronic kidney disease, and undertreated diabetes. Peripheral arterial disease signals multiterritory atherosclerosis and usually intensifies secondary-prevention targets.

Supply–demand mismatch without plaque rupture—tachyarrhythmia, severe dysrhythmia, anaemia, thyrotoxicosis, or hypertrophic gradients—can provoke angina-type pain in patients who also have underlying coronary disease; cast a wide net when the rate–rhythm strip or haemoglobin does not match “stable exertional” wording.

Clinical assessment

History should quantify CCS class, medication adherence, recent dose changes, PDE5 inhibitor or similar drug exposure before nitrates, cocaine or stimulant use, and prior catheter results. Vitals including bilateral blood pressures (dissection cue when unequal) belong in every exacerbation.

Laboratory investigations

Fasting lipids, A1c or glucose, renal function, full blood count (anaemia, thrombocytopenia affecting antiplatelet choice), and thyroid tests enter many baseline work-ups. When symptoms are acute or unstable, layered high-sensitivity troponin sampling distinguishes myocardial infarction from angina without necrosis—never delegate timing to guesswork.

Imaging and functional testing

Resting ECG may be normal between attacks yet still establishes rhythm and prior infarct Q-waves. Stress echocardiography, nuclear perfusion imaging, cardiac magnetic resonance, or CT coronary angiography stratify ischaemia/anatomy when pre-test probability sits in intermediate range. Invasive angiography remains definitive for high-risk features or refractory symptoms despite guideline-directed medical therapy (GDMT).

Diagnostic criteria and risk tools

Combine clinical scores (inspired by Diamond–Forrester / updated Bayesian concepts), imaging, and biomarkers rather than relying on text-book descriptions alone. Multidisciplinary rapid-access chest pain clinics align with NICE CG95 themes for stable versus acute presentations.

1. Unsafe features? Hypotension, unrelieved rest pain, rapidly escalating CCS class, ventricular arrhythmia, acute pulmonary oedema—move to emergency ACS pathway, two intravenous lines if instability, telemetry, serial ECGs, troponins per algorithm (IV access per scope).
2. Stable suspected angina? Arrange prompt outpatient cardiology review with objective testing; start beta-blocker or calcium antagonist plus nitrate bridge only under prescriber orders once contraindications reviewed.
3. After positive testing or high coronary calcium burden: escalate to coronary angiography when symptoms, non-invasive findings, or professional society thresholds align; nurses coordinate fasting, anticoagulant holds, contrast allergy precautions, and oxygen only if hypoxaemic.
4. Post-revascularisation: reconcile aspirin, P2Y₁₂ duration, statin intensity, beta-blocker taper plan, and rehab referral before discharge.

↔On a small screen, swipe or scroll sideways to see the full table.

Stable angina tracks predictable exertional thresholds, settles within minutes, and shows benign biomarker kinetics when objectively tested during a quiet phase. Acute coronary syndrome implies plaque instability or occlusion physiology: symptoms at rest or with minimal effort, accelerating pattern over days, ST deviations, or troponin release. Ward teams treat crossing that line as a new emergency presentation even if the patient carries a chronic diagnosis card.

First-line antianginal therapy

Beta-blockers (often metoprolol-based regimens) or calcium channel blockers such as amlodipine lower myocardial oxygen demand; short-acting nitrates abort breakthrough pain. Choice reflects resting heart rate, blood pressure, asthma/COPD history, conduction disease, and peripheral oedema profile.

Second-line / adjunct options

Long-acting nitrates, late sodium channel inhibitors, or ranolazine enter when first-line agents max out or intolerance appears—selection belongs to cardiology or advanced practice prescribers with pharmacy support.

Secondary prevention (GDMT)

High-intensity statins (atorvastatin class), blood pressure control, dual-pathway antiplatelet therapy durations after PCI, and renin–angiotensin modulation when comorbidities dictate reduce future MI and mortality; align each element to the ACC/AHA chronic coronary disease document you adopt locally.

Revascularisation

Percutaneous coronary intervention and coronary artery bypass grafting relieve lifestyle-limiting angina when anatomy suits and systemic fitness allows. Shared decision-making should document expected symptom gain versus procedural bleed and renal risks.

Maintain a dated angina plan: CCS class, prescribed nitrate frequency, blood pressure and pulse guardrails after beta-blocker titration, bleeding precautions on aspirin plus clopidogrel, and explicit triggers for emergency return. Recheck within days to weeks after antianginal initiation or dose change, then at guideline intervals when stable.

• Teach patients to record episodes (time, activity, GTN dose, relief) and bring logs to clinic—improves MDT decision-making.
• Pair pharmacy reconciliation with every admission: abrupt beta-blocker cessation can rebound; accidental duplicate antiplatelets raise bleed odds.
• Arrange cardiac rehabilitation handoffs before discharge whenever service eligibility criteria are met.

• ACS from plaque rupture—surveillance bias toward “known angina” delays catheter lab activation.
• Ischaemic left ventricular dysfunction with reduced effort tolerance or flash pulmonary oedema.
• Malignant arrhythmia during exercise or ischaemia—telemetry and crash-cart readiness during stress testing.

Clinician-facing prevention emphasises tobacco cessation, blood pressure and A1c control, lipid lowering, influenza vaccination where indicated, influenza-like illness follow-up when ischaemic symptoms surge, and weight management when obesity magnifies demand. Document adherence barriers (cost, health literacy) and refer to community programmes mirroring WHO cardiovascular prevention messages.

Prognosis tracks left ventricular function, anatomic disease burden, comorbid diabetes or CKD, symptom stability on GDMT, and revascularisation completeness. Stable CCS I–II patients adhering to therapy often retain good function for years; rising class despite therapy flags higher event risk and demands expedited review—not reassurance alone.

Interpret telemetric alarms alongside symptoms: rate-related ST shifts in someone with known three-vessel disease still warrant ECG capture even if vitals look “soft normal”. Use teach-back for nitrate use (when to call emergency, how many doses, what defines no relief). Note language barriers; family translators must not replace professional interpretation services when high-risk decisions unfold.

• Vitals & perfusion: pre- and post-nitrate BP/HR, orthostatic symptoms, SpO₂, urinary output if diuresis active.
• Ischaemia cues: pain score trend, diaphoresis, nausea, new murmur, bilateral lung crackles.
• Rhythm / device: pause-induced symptoms, pacemaker dependence, ICD shocks—escalate per telemetry policy.
• Bleeding & antiplatelets: gum bleeds, melena, unexpected Hb drop—especially on dual therapy after PCI.

• Angina unrelieved after repeat prescribed nitrates with rest, or escalating over minutes with autonomic features.
• Sudden syncope, sustained palpitations with hypotension, or new neurologic deficit.
• Suspected ACS equivalents in high-risk patients even when verbal descriptors are vague.

Worsening ischaemia on monitors, recurring ventricular ectopy or non-sustained VT, repeated GTN use within short intervals, acute pulmonary oedema, or clinician intuition that “this is not their baseline” should trigger rapid response / MET per local policy while cardiology and senior medical officers coalesce the plan.

Pre- and post-procedure

• Confirm renal profile, NPO status, antiplatelet continuity instructions, and allergy band accuracy before catheter lab transfer.

Education

• Rehearse nitrate administration, driving rules after syncopal episodes, and BLS awareness for household members when risk dictates.

Evaluation

• Close the loop on follow-up phone calls after clinic titration—did angina frequency shift one CCS band?

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze drops on the topic of stable angina assessment, GTN / beta-blocker / calcium-channel blocker stewardship, secondary prevention and recognition of acute coronary syndrome.